Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taibidi Pharmaceutical Technology is a specialized contract research and manufacturing organization (CRO/CDMO) focusing on high-end chemical reagents, chiral catalysts, and pharmaceutical intermediates. Based in Huzhou, China, the company provides comprehensive services ranging from laboratory-scale R&D and process optimization to pilot production and commercial manufacturing. Taibidi is particularly recognized for its technical expertise in asymmetric catalysis and metal-catalyzed cross-coupling reactions, maintaining an extensive catalog of specialty ligands and building blocks. By integrating advanced synthetic chemistry with robust industrial-scale production capabilities, the company supports global pharmaceutical and biotech firms in the efficient development of complex small molecule therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taibidi Pharmaceutical Technology.